These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8286806)

  • 1. Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
    Wragge TM; Cooper BE
    Ann Pharmacother; 1993 Nov; 27(11):1346-8. PubMed ID: 8286806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series.
    Onor IO; Neuliep A; Tran KA; Lambert J; Gillard CJ; Brakta F; Ezebuenyi MC; St James K; Okogbaa JI; Beyl RA
    Drugs R D; 2020 Jun; 20(2):83-93. PubMed ID: 32166646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Larger Dose of Vancomycin Is Required in Adult Neurosurgical Intensive Care Unit Patients Due to Augmented Clearance.
    Lin Wu FL; Liu SS; Yang TY; Win MF; Lin SW; Huang CF; Wang KC; Shen LJ
    Ther Drug Monit; 2015 Oct; 37(5):609-18. PubMed ID: 25627406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.
    del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A
    Intensive Care Med; 2007 Feb; 33(2):279-85. PubMed ID: 17165021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Analysis of Various Dosing Methods for Aminoglycosides and Vancomycin Therapy in Chronic Spinal Cord Injury Patients.
    Lee JP; Truong TT
    Nephron; 2015; 131(1):66-72. PubMed ID: 26330088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F; Uehlinger DE
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis.
    Jennings DL; Makowski CT; Chambers RM; Lanfear DE
    Int J Artif Organs; 2014 Mar; 37(3):270-4. PubMed ID: 24619894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside pharmacokinetic parameters in neurocritical care patients undergoing induced hypothermia.
    Mercer JM; Neyens RR
    Pharmacotherapy; 2010 Jul; 30(7):654-60. PubMed ID: 20575630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased vancomycin clearance in patients with congestive heart failure.
    Shimamoto Y; Fukuda T; Tominari S; Fukumoto K; Ueno K; Dong M; Tanaka K; Shirasaka T; Komori K
    Eur J Clin Pharmacol; 2013 Mar; 69(3):449-57. PubMed ID: 22791272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of vancomycin for appropriate dosing in severe infective patients with augmented renal clearance].
    Liu N; Zhang B; Liu Y; Tang J; Dong D; Gu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):646-651. PubMed ID: 30045791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls.
    Lavezo LA; Davis RL
    J Spinal Cord Med; 1995 Oct; 18(4):233-5. PubMed ID: 8591068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of methods to estimate glomerular filtration rate versus actual drug clearance in patients with chronic spinal cord injury.
    Lee JP; Dang AT
    Spinal Cord; 2011 Dec; 49(12):1158-63. PubMed ID: 21788951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.